Teva Pharmaceutical Industries Ltd.
(NYSE: TEVA)
|
4:01 PM EST, 12/11/19 | |||
---|---|---|---|---|
Last: $9.56 | Change: +0.07 | %Change: +0.74% | Volume: 10,169,403 |
Open: | $ 9.45 | Volume: | 10,169,403 | |
---|---|---|---|---|
High: | $ 9.60 | Yield(%) | n/a | |
Low: | $ 9.38 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 10.36B | |
EPS ($) | n/a | Shares Out: | 1.09B |
% Price Change (last 4 weeks): | -1.25 |
---|---|
% Price Change (last 13 weeks): | 16.73 |
% Price Change (last 26 weeks): | 4.52 |
% Price Change (last 52 weeks): | -48.73 |
% Price Change (year to date): | -40.13 |
Return on Equity (%): | -13.37 |
---|---|
Return on Assets (%): | -3.26 |
Return on Invested Capital (%): | -3.91 |
Gross Profit Margin (%): | 44.00 |
---|---|
Net Profit Margin (%): | -11.40 |
Operating Profit Margin (%): | 15.22 |
|
|
50-day Moving Average: | $8.72 |
---|---|
200-day Moving Average: | $10.26 |
Avg. Daily Vol. (last 50 days): | 21,391,645 |
Avg. Daily Vol. (last 200 days): | 18,480,419 |
52-wk high: | $20.21 |
52-wk low: | $6.07 |
Bid: | $9.54 |
Ask: | $9.60 |
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
|
Teva Pharmaceutical Industries Ltd.
5 Basel Street Petach Tikva HM 49131 Phone: 972.3.926.7267 Fax: 972.3.923.4050 http://www.tevapharm.com |
Earnings (1year) ($): | -3.85 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 13.49 |
Cash Flow ($): | -0.51 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.84 |
Price/Book (x): | 1.14 |
Price/Cash Flow (x): | 3.78 |
Quick Ratio (x): | 0.63 |
---|---|
Current Ratio (x): | 0.96 |
LT Debt/Equity (x): | 181.55 |
Total Debt/Equity (x): | 196.61 |